{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:40:40Z","timestamp":1789026040838,"version":"build-2803163510"},"reference-count":38,"publisher":"The Endocrine Society","issue":"8","license":[{"start":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T00:00:00Z","timestamp":1676592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Lisa"},{"name":"Johan Gr\u00f6nberg foundation"},{"DOI":"10.13039\/100016409","name":"Gyllenstiernska Krapperup Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016409","id-type":"DOI","asserted-by":"publisher"}]},{"name":"S\u00f6dra sjukv\u00e5rdsregionen"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Mild autonomous cortisol secretion (MACS) is associated with increased mortality in patients with adrenal incidentalomas, but little is known regarding the potential risk associated with nonfunctional adrenal adenomas (NFAA), which constitute the majority of adrenal incidentalomas.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Compare mortality risk in patients with NFAA, and different levels of MACS, to matched controls.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Method<\/jats:title>\n                  <jats:p>This was a retrospective matched cohort study. All patients referred to 2 endocrine centers in southern Sweden because of an adrenal incidentaloma between 2005 and 2015 were enrolled. Controls (3:1) matched for sex, age, and residency were included. Primary endpoint was all-cause mortality. Outcome data were obtained from the Cause of Death Register. Patients were grouped according to cortisol level post 1-mg dexamethasone suppression test (cortisolDST) (&amp;lt;50 (NFAA), 50-82, 83-137, and \u2265138 nmol\/L).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>1154 patients and 3462 matched controls were included. During a median follow-up of 6.6 years, 210 patients and 505 controls died. There were no statistically significant differences in mortality between patients with NFAA and their controls (HR 1.13 [0.87-1.46]) whereas mortality was increased compared to controls in patients with cortisolDST 83-137 (HR 1.99 [1.38-2.88]) and \u2265138 nmol\/L (HR 4.09 [2.41-6.93]). Likewise, the mortality risk was increased in patients younger than 65 years with cortisolDST 50-82 nmol\/L compared with controls (HR 2.33 [1.30-4.17]).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>NFAA does not seem to pose a clinically relevant risk for increased mortality in patients with adrenal incidentalomas while patients with MACS, and especially younger patients and those with cortisolDST \u226583 nmol\/L, have significantly increased mortality risk compared with matched controls.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgad074","type":"journal-article","created":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T17:29:16Z","timestamp":1676654956000},"page":"e536-e541","source":"Crossref","is-referenced-by-count":21,"title":["Mortality Not Increased in Patients With Nonfunctional Adrenal Adenomas: A Matched Cohort Study"],"prefix":"10.1210","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4886-4807","authenticated-orcid":false,"given":"Albin","family":"Kjellbom","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Sk\u00e5ne University Hospital , Lasarettsgatan 15, SE-221 85, Lund , Sweden"},{"name":"Faculty of Medicine, Department of Clinical Sciences Lund, Lund University , Office DCSL, H\u00e4mtst\u00e4lle 66, BMC F12, SE-221 84, Lund , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Lindgren","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Sk\u00e5ne University Hospital , Lasarettsgatan 15, SE-221 85, Lund , Sweden"},{"name":"Faculty of Medicine, Department of Clinical Sciences Lund, Lund University , Office DCSL, H\u00e4mtst\u00e4lle 66, BMC F12, SE-221 84, Lund , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin","family":"Danielsson","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Sk\u00e5ne University Hospital , Lasarettsgatan 15, SE-221 85, Lund , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Olsen","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Department of Clinical Sciences Lund, Lund University , Office DCSL, H\u00e4mtst\u00e4lle 66, BMC F12, SE-221 84, Lund , Sweden"},{"name":"Department of Endocrinology, \u00c4ngelholm Hospital , \u00c4ngelholms sjukhus, SE-262 81, \u00c4ngelholm , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"L\u00f6ndahl","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Sk\u00e5ne University Hospital , Lasarettsgatan 15, SE-221 85, Lund , Sweden"},{"name":"Faculty of Medicine, Department of Clinical Sciences Lund, Lund University , Office DCSL, H\u00e4mtst\u00e4lle 66, BMC F12, SE-221 84, Lund , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2023,2,17]]},"reference":[{"issue":"2","key":"2023071417162198900_dgad074-B1","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European Society of Endocrinology clinical practice guideline in collaboration with the European Network for the Study of Adrenal Tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"1-6","key":"2023071417162198900_dgad074-B2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.0954-6820.1968.tb02445.x","article-title":"On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes","volume":"184","author":"Hedeland","year":"1968","journal-title":"Acta Med Scand"},{"issue":"12","key":"2023071417162198900_dgad074-B3","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1210\/jc.2014-3007","article-title":"Cortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas","volume":"99","author":"Debono","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2023071417162198900_dgad074-B4","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S2213-8587(13)70211-0","article-title":"Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study","volume":"2","author":"Di Dalmazi","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"2023071417162198900_dgad074-B5","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s12020-017-1400-8","article-title":"Increased mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: a 13-year retrospective study from one center","volume":"58","author":"Patrova","year":"2017","journal-title":"Endocrine"},{"issue":"8","key":"2023071417162198900_dgad074-B6","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.7326\/M20-7946","article-title":"Association between mortality and levels of autonomous cortisol secretion by adrenal incidentalomas: a cohort study","volume":"174","author":"Kjellbom","year":"2021","journal-title":"Ann Intern Med"},{"issue":"7","key":"2023071417162198900_dgad074-B7","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S2213-8587(22)00100-0","article-title":"Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study","volume":"10","author":"Deutschbein","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"2023071417162198900_dgad074-B8","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/cen.14745","article-title":"Cardiometabolic profile and urinary metabolomic alterations in non-functioning adrenal incidentalomas: a review","volume":"97","author":"Araujo-Castro","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"446","key":"2023071417162198900_dgad074-B9","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"33","key":"2023071417162198900_dgad074-B10","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"issue":"8","key":"2023071417162198900_dgad074-B11","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1210\/jc.2013-4064","article-title":"Patients with apparently nonfunctioning adrenal incidentalomas may be at increased cardiovascular risk due to excessive cortisol secretion","volume":"99","author":"Androulakis","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2023071417162198900_dgad074-B12","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.metabol.2010.01.007","article-title":"Insulin resistance and metabolic syndrome in patients with nonfunctioning adrenal incidentalomas: a cause-effect relationship?","volume":"59","author":"Peppa","year":"2010","journal-title":"Metabolism"},{"issue":"1","key":"2023071417162198900_dgad074-B13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41371-017-0011-4","article-title":"The presence of nonfunctioning adrenal incidentalomas increases arterial hypertension frequency and severity, and is associated with cortisol levels after dexamethasone suppression test","volume":"32","author":"Arruda","year":"2017","journal-title":"J Hum Hypertens"},{"issue":"8","key":"2023071417162198900_dgad074-B14","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/M16-0547","article-title":"\u201cNonfunctional\u201d adrenal tumors and the risk for incident diabetes and cardiovascular outcomes: a cohort study","volume":"165","author":"Lopez","year":"2016","journal-title":"Ann Intern Med"},{"issue":"8","key":"2023071417162198900_dgad074-B15","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s40618-014-0106-5","article-title":"Non-functioning adrenal incidentalomas are associated with higher hypertension prevalence and higher risk of atherosclerosis","volume":"37","author":"Tuna","year":"2014","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"2023071417162198900_dgad074-B16","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s40618-020-01360-z","article-title":"Cortisol level after dexamethasone suppression test in patients with non-functioning adrenal incidentaloma is positively associated with the duration of reactive hyperemia response on microvascular bed","volume":"44","author":"de Paula","year":"2021","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2023071417162198900_dgad074-B17","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s12020-021-02741-x","article-title":"Nonfunctional adrenal adenomas and impaired glucose metabolism: a systematic review and meta-analysis","volume":"74","author":"Athanasouli","year":"2021","journal-title":"Endocrine"},{"issue":"7","key":"2023071417162198900_dgad074-B18","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","article-title":"Complications of Cushing's syndrome: state of the art","volume":"4","author":"Pivonello","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2023071417162198900_dgad074-B19","volume-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988","edition":"2nd ed"},{"issue":"8","key":"2023071417162198900_dgad074-B20","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/cncr.29924","article-title":"A note on the magnitude of hazard ratios","volume":"122","author":"Azuero","year":"2016","journal-title":"Cancer"},{"issue":"1","key":"2023071417162198900_dgad074-B21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/sim.4780050106","article-title":"Choosing the number of controls in a matched case-control study, some sample size, power and efficiency considerations","volume":"5","author":"Taylor","year":"1986","journal-title":"Stat Med"},{"issue":"9","key":"2023071417162198900_dgad074-B22","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s10654-017-0316-1","article-title":"The Swedish cause of death register","volume":"32","author":"Brooke","year":"2017","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"2023071417162198900_dgad074-B23","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/1471-2458-8-340","article-title":"Socio-economic status and overall and cause-specific mortality in Sweden","volume":"8","author":"Weires","year":"2008","journal-title":"BMC Public Health"},{"issue":"9464","key":"2023071417162198900_dgad074-B24","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0140-6736(05)71146-6","article-title":"Social determinants of health inequalities","volume":"365","author":"Marmot","year":"2005","journal-title":"Lancet"},{"key":"2023071417162198900_dgad074-B25","author":"Statistics Sweden"},{"key":"2023071417162198900_dgad074-B26","doi-asserted-by":"crossref","first-page":"g7731","DOI":"10.1136\/bmj.g7731","article-title":"Bias in observational study designs, prospective cohort studies","volume":"349","author":"Sedgwick","year":"2014","journal-title":"BMJ"},{"issue":"3","key":"2023071417162198900_dgad074-B27","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1530\/EJE-20-0033","article-title":"High prevalence of smoking in patients with adrenal incidentalomas: causality or case selection?","volume":"183","author":"Olsen","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"2023071417162198900_dgad074-B28","doi-asserted-by":"crossref","first-page":"e0143084","DOI":"10.1371\/journal.pone.0143084","article-title":"Diabetes prevalence in Sweden at present and projections for year 2050","volume":"10","author":"Andersson","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"2023071417162198900_dgad074-B29","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"issue":"10","key":"2023071417162198900_dgad074-B30","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1001\/jamasurg.2022.3544","article-title":"American Association of Endocrine Surgeons guidelines for adrenalectomy: executive summary","volume":"157","author":"Yip","year":"2022","journal-title":"JAMA Surg"},{"issue":"2","key":"2023071417162198900_dgad074-B31","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3803\/EnM.2017.32.2.200","article-title":"Clinical guidelines for the management of adrenal incidentaloma","volume":"32","author":"Lee","year":"2017","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"4","key":"2023071417162198900_dgad074-B32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1507\/endocrj.EJ17-0456","article-title":"New diagnostic criteria of adrenal subclinical Cushing's syndrome: opinion from the Japan Endocrine Society","volume":"65","author":"Yanase","year":"2018","journal-title":"Endocr J"},{"issue":"6","key":"2023071417162198900_dgad074-B33","doi-asserted-by":"crossref","first-page":"R283","DOI":"10.1530\/EJE-16-0465","article-title":"THERAPY OF ENDOCRINE DISEASE: improvement of cardiovascular risk factors after adrenalectomy in patients with adrenal tumors and subclinical Cushing's syndrome: a systematic review and meta-analysis","volume":"175","author":"Bancos","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2023071417162198900_dgad074-B34","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/bjs.9742","article-title":"Systematic review of surgical treatment of subclinical Cushing's syndrome","volume":"102","author":"Iacobone","year":"2015","journal-title":"Br J Surg"},{"issue":"9","key":"2023071417162198900_dgad074-B35","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1210\/jc.2017-00823","article-title":"Resetting the abnormal circadian cortisol rhythm in adrenal incidentaloma patients with mild autonomous cortisol secretion","volume":"102","author":"Debono","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2023071417162198900_dgad074-B36","doi-asserted-by":"crossref","first-page":"846","DOI":"10.4158\/EP-2019-0047","article-title":"Mifepristone treatment for mild autonomous cortisol secretion due to adrenal adenomas: a pilot study","volume":"25","author":"Belokovskaya","year":"2019","journal-title":"Endocr Pract"},{"issue":"4","key":"2023071417162198900_dgad074-B37","doi-asserted-by":"crossref","first-page":"e60984","DOI":"10.1371\/journal.pone.0060984","article-title":"Mifepristone reduces insulin resistance in patient volunteers with adrenal incidentalomas that secrete low levels of cortisol: a pilot study","volume":"8","author":"Debono","year":"2013","journal-title":"PLoS One"},{"key":"2023071417162198900_dgad074-B38","doi-asserted-by":"crossref","first-page":"662865","DOI":"10.3389\/fendo.2021.662865","article-title":"Relacorilant, a selective glucocorticoid receptor modulator, induces clinical improvements in patients with Cushing syndrome: results from a prospective, open-label phase 2 study","volume":"12","author":"Pivonello","year":"2021","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgad074\/50455834\/dgad074.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/108\/8\/e536\/50884411\/dgad074.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/108\/8\/e536\/50884411\/dgad074.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T17:17:09Z","timestamp":1689355029000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/108\/8\/e536\/7044760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,17]]},"references-count":38,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,2,17]]},"published-print":{"date-parts":[[2023,7,14]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgad074","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,8]]},"published":{"date-parts":[[2023,2,17]]}}}